Wellinghoff Darryl 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Nov 19, 2019
Insider Transaction Report
Form 4
Wellinghoff Darryl
Chief Commercial Officer
Transactions
- Award
Common Stock
2019-11-15$5.12/sh+311$1,592→ 3,528 total - Award
Stock Option (Right to Buy)
2019-11-15+311→ 311 totalExercise: $6.02Exp: 2029-11-15→ Common Stock (311 underlying)
Footnotes (2)
- [F1]These shares were acquired on 11/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.